Drostanolone - Beligas Pharmaceuticals https://beligas.org Strength in Precision Mon, 13 May 2024 14:33:17 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.1 https://beligas.org/wp-content/uploads/2022/04/beligas_logo_trans-100x100.png Drostanolone - Beligas Pharmaceuticals https://beligas.org 32 32 Etho®- Masteron 200mg/mL https://beligas.org/product/etho-masteron-200mg-ml/?utm_source=rss&utm_medium=rss&utm_campaign=etho-masteron-200mg-ml&utm_source=rss&utm_medium=rss&utm_campaign=etho-masteron-200mg-ml Sun, 17 May 2020 03:30:20 +0000 https://beligas.org/?post_type=product&p=26722 ACTIVE INGREDIENT: DROSTANOLONE ENANTHATE
ACTIVE HALF-LIFE: 8-10 DAYS
CLASSIFICATION: ANDROGENIC/ANABOLIC STEROID
DOSAGE: 400-600MG PER WEEK
ACNE: POSSIBLE
WATER RETENTION: NONE
HEPATOTOXICITY: LOW
AROMATIZATION: NONE

The post Etho®- Masteron 200mg/mL first appeared on Beligas Pharmaceuticals.

]]> ACTIVE INGREDIENT: DROSTANOLONE ENANTHATE
ACTIVE HALF-LIFE: 8-10 DAYS
CLASSIFICATION: ANDROGENIC/ANABOLIC STEROID
DOSAGE: 400-600MG PER WEEK
ACNE: POSSIBLE
WATER RETENTION: NONE
HEPATOTOXICITY: LOW
AROMATIZATION: NONE

The post Etho®- Masteron 200mg/mL first appeared on Beligas Pharmaceuticals.

]]> Propha®- Masteron 100mg/mL https://beligas.org/product/propha-masteron-100mg-ml/?utm_source=rss&utm_medium=rss&utm_campaign=propha-masteron-100mg-ml&utm_source=rss&utm_medium=rss&utm_campaign=propha-masteron-100mg-ml Sun, 17 May 2020 03:30:19 +0000 https://beligas.org/?post_type=product&p=26715 ACTIVE INGREDIENT: DROSTANOLONE PROPIONATE
ACTIVE HALF-LIFE: 2.5-3 DAYS
CLASSIFICATION: ANDROGENIC/ANABOLIC STEROID
DOSAGE: 300-500MG PER WEEK
ACNE: POSSIBLE
WATER RETENTION: LOW
HEPATOTOXICITY: LOW
AROMATIZATION: NONE

The post Propha®- Masteron 100mg/mL first appeared on Beligas Pharmaceuticals.

]]> ACTIVE INGREDIENT: DROSTANOLONE PROPIONATE
ACTIVE HALF-LIFE: 2.5-3 DAYS
CLASSIFICATION: ANDROGENIC/ANABOLIC STEROID
DOSAGE: 300-500MG PER WEEK
ACNE: POSSIBLE
WATER RETENTION: LOW
HEPATOTOXICITY: LOW
AROMATIZATION: NONE

The post Propha®- Masteron 100mg/mL first appeared on Beligas Pharmaceuticals.

]]>